2023. Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s124. DOI:https://doi.org/10.25251/skin.7.supp.124.